The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-09-13

AUTHORS

Yasushi Adachi, Hirokazu Ohashi, Arisa Imsumran, Hiroyuki Yamamoto, Yasutaka Matsunaga, Hiroaki Taniguchi, Katsuhiko Nosho, Hiromu Suzuki, Yasushi Sasaki, Yoshiaki Arimura, David P Carbone, Kohzoh Imai, Yasuhisa Shinomura

ABSTRACT

Insulin-like growth factor-I receptor (IGF-IR) signaling is required for carcinogenicity and tumor development, and this pathway has not been well studied in human esophageal carcinomas. Esophageal cancer is one of the human cancers with the worst prognosis and has two main histologies: squamous cell carcinomas (ESCC) and adenocarcinoma (EAC). Previously, we have reported that detection of the IGF axis may be useful for the prediction of recurrence and poor prognosis of ESCC. We have also shown the successful therapy for several gastrointestinal cancers using recombinant adenoviruses expressing dominant negative IGF-IR (ad-IGF-IR/dn). The aim of this study is to develop potential targeted therapeutics to IGF-IR and to assess the effect of IGF-IR blockade in both of these types of esophageal cancer. We determined immunohistochemical expression of IGF-IR in a tissue microarray. We then assessed the effect of IGF-IR blockade on signal transduction, proliferation, apoptosis, and motility. Ad-IGF-IR/dn, a tyrosine kinase inhibitor, BMS-536924, and adenovirus expressing shRNA for IGF-IR were used. IGF-IR expression was common in both tumor types but not in normal tissues. IGF-IR was detected in metastatic sites at similar levels compared to the primary site. IGF-IR inhibition suppressed proliferation and colony formation in both cancers. IGF-IR blockades up-regulated both stress- and chemotherapy-induced apoptosis and reduced migration. Although IGF-IR/dn blocked ligand-induced activation of Akt-1 mainly, BMS-536924 effectively blocked both activation of Akt and MAPK. The IGF axis might play a key role in tumor progression of esophageal carcinomas. The IGF-IR targeting strategies might thus be useful anticancer therapeutics for human esophageal malignancies. More... »

PAGES

973-985

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13277-013-1131-2

DOI

http://dx.doi.org/10.1007/s13277-013-1131-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000207016

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24026884


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenoviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Squamous Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Esophageal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Esophageal Squamous Cell Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin-Like Growth Factor I", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Targeted Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, IGF Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adachi", 
        "givenName": "Yasushi", 
        "id": "sg:person.01110335104.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110335104.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohashi", 
        "givenName": "Hirokazu", 
        "id": "sg:person.01371070550.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371070550.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Imsumran", 
        "givenName": "Arisa", 
        "id": "sg:person.01072025765.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072025765.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamamoto", 
        "givenName": "Hiroyuki", 
        "id": "sg:person.0635431612.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635431612.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsunaga", 
        "givenName": "Yasutaka", 
        "id": "sg:person.0764564242.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764564242.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Institute of Medical Science, The University of Tokyo, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taniguchi", 
        "givenName": "Hiroaki", 
        "id": "sg:person.01274720725.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274720725.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nosho", 
        "givenName": "Katsuhiko", 
        "id": "sg:person.01074665575.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074665575.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Hiromu", 
        "id": "sg:person.014315602124.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014315602124.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sasaki", 
        "givenName": "Yasushi", 
        "id": "sg:person.013060476532.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013060476532.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arimura", 
        "givenName": "Yoshiaki", 
        "id": "sg:person.01317767674.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317767674.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "James Thoracic Center, The Ohio State University, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "James Thoracic Center, The Ohio State University, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carbone", 
        "givenName": "David P", 
        "id": "sg:person.01301010573.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301010573.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Institute of Medical Science, The University of Tokyo, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
            "The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Imai", 
        "givenName": "Kohzoh", 
        "id": "sg:person.0762051764.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762051764.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.263171.0", 
          "name": [
            "First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shinomura", 
        "givenName": "Yasuhisa", 
        "id": "sg:person.0643127340.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643127340.79"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00535-009-0151-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023037865", 
          "https://doi.org/10.1007/s00535-009-0151-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02254995", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011834346", 
          "https://doi.org/10.1007/bf02254995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1745-7254.2007.00554.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042563001", 
          "https://doi.org/10.1111/j.1745-7254.2007.00554.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10495-010-0555-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042036765", 
          "https://doi.org/10.1007/s10495-010-0555-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1206772", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038051388", 
          "https://doi.org/10.1038/sj.onc.1206772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2011.417", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014758355", 
          "https://doi.org/10.1038/ajg.2011.417"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cgt.7700524", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018453497", 
          "https://doi.org/10.1038/sj.cgt.7700524"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-09-13", 
    "datePublishedReg": "2013-09-13", 
    "description": "Insulin-like growth factor-I receptor (IGF-IR) signaling is required for carcinogenicity and tumor development, and this pathway has not been well studied in human esophageal carcinomas. Esophageal cancer is one of the human cancers with the worst prognosis and has two main histologies: squamous cell carcinomas (ESCC) and adenocarcinoma (EAC). Previously, we have reported that detection of the IGF axis may be useful for the prediction of recurrence and poor prognosis of ESCC. We have also shown the successful therapy for several gastrointestinal cancers using recombinant adenoviruses expressing dominant negative IGF-IR (ad-IGF-IR/dn). The aim of this study is to develop potential targeted therapeutics to IGF-IR and to assess the effect of IGF-IR blockade in both of these types of esophageal cancer. We determined immunohistochemical expression of IGF-IR in a tissue microarray. We then assessed the effect of IGF-IR blockade on signal transduction, proliferation, apoptosis, and motility. Ad-IGF-IR/dn, a tyrosine kinase inhibitor, BMS-536924, and adenovirus expressing shRNA for IGF-IR were used. IGF-IR expression was common in both tumor types but not in normal tissues. IGF-IR was detected in metastatic sites at similar levels compared to the primary site. IGF-IR inhibition suppressed proliferation and colony formation in both cancers. IGF-IR blockades up-regulated both stress- and chemotherapy-induced apoptosis and reduced migration. Although IGF-IR/dn blocked ligand-induced activation of Akt-1 mainly, BMS-536924 effectively blocked both activation of Akt and MAPK. The IGF axis might play a key role in tumor progression of esophageal carcinomas. The IGF-IR targeting strategies might thus be useful anticancer therapeutics for human esophageal malignancies.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13277-013-1131-2", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6047187", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6092555", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6060341", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6155796", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6069476", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6029765", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1091981", 
        "issn": [
          "1010-4283", 
          "1423-0380"
        ], 
        "name": "Tumor Biology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "35"
      }
    ], 
    "keywords": [
      "IGF-IR blockade", 
      "squamous cell carcinoma", 
      "IGF-IR", 
      "IGF axis", 
      "cell carcinoma", 
      "esophageal cancer", 
      "esophageal carcinoma", 
      "BMS-536924", 
      "human esophageal squamous cell carcinoma", 
      "insulin-like growth factor-I receptor (IGF-IR) signaling", 
      "esophageal squamous cell carcinoma", 
      "dominant negative IGF-IR", 
      "IGF-IR/", 
      "IGF-IR inhibition", 
      "IGF-IR expression", 
      "prediction of recurrence", 
      "tyrosine kinase inhibitors", 
      "human esophageal carcinoma", 
      "chemotherapy-induced apoptosis", 
      "main histology", 
      "receptor blockade", 
      "worse prognosis", 
      "metastatic sites", 
      "poor prognosis", 
      "gastrointestinal cancer", 
      "esophageal malignancy", 
      "activation of Akt", 
      "immunohistochemical expression", 
      "successful therapy", 
      "tissue microarray", 
      "tumor types", 
      "primary site", 
      "carcinoma", 
      "tumor progression", 
      "cancer", 
      "normal tissues", 
      "tumor development", 
      "receptor signaling", 
      "blockade", 
      "kinase inhibitors", 
      "recombinant adenovirus", 
      "Ad-IGF", 
      "ligand-induced activation", 
      "human cancers", 
      "colony formation", 
      "adenocarcinoma", 
      "prognosis", 
      "Akt-1", 
      "anticancer therapeutics", 
      "adenovirus", 
      "apoptosis", 
      "therapeutics", 
      "proliferation", 
      "similar levels", 
      "activation", 
      "recurrence", 
      "malignancy", 
      "ESCC", 
      "therapy", 
      "expression", 
      "histology", 
      "progression", 
      "signal transduction", 
      "key role", 
      "shRNA", 
      "Akt", 
      "inhibitors", 
      "carcinogenicity", 
      "effect", 
      "inhibition", 
      "tissue", 
      "MAPK", 
      "signaling", 
      "motility", 
      "aim", 
      "microarray", 
      "pathway", 
      "axis", 
      "levels", 
      "sites", 
      "study", 
      "role", 
      "transduction", 
      "types", 
      "migration", 
      "stress", 
      "development", 
      "strategies", 
      "detection", 
      "DN", 
      "formation", 
      "prediction"
    ], 
    "name": "The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma", 
    "pagination": "973-985", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000207016"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13277-013-1131-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24026884"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13277-013-1131-2", 
      "https://app.dimensions.ai/details/publication/pub.1000207016"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_612.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13277-013-1131-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13277-013-1131-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13277-013-1131-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13277-013-1131-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13277-013-1131-2'


 

This table displays all metadata directly associated to this object as RDF triples.

340 TRIPLES      21 PREDICATES      138 URIs      123 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13277-013-1131-2 schema:about N0e6a26be96254e6a929773df3af746a2
2 N290c8a21be8747d6bf00015d4b581a67
3 N2bdf4f9843044158bfcbcb91bd8ef4cd
4 N305ff2f6227c4c6e90a1ab4b8680a467
5 N345582aea88d4de59deabf4f4a2c23e6
6 N40ab97e75a0f4ebda6898b302cb4a60f
7 N5058c8aa27e3432db8e86d88f07b5907
8 N55d2a1b81a134e2caf48a8d38bdddadd
9 N8b8355ab1126484aaf96738b740f2580
10 Nc9c84975349a4671a1778ced9d687cc3
11 Ncdf6d9e64c8d4e2ca61b9615916129ae
12 Nd9565dc8453f4d5ab18475068522e3dc
13 Nef78446823b24a2398534db8c0e0a975
14 Nfa2c1c325a3f439589a20edc59aea1d6
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author Nef831876dc314821810957bd5b41bbb6
18 schema:citation sg:pub.10.1007/bf02254995
19 sg:pub.10.1007/s00535-009-0151-6
20 sg:pub.10.1007/s10495-010-0555-z
21 sg:pub.10.1038/ajg.2011.417
22 sg:pub.10.1038/sj.cgt.7700524
23 sg:pub.10.1038/sj.onc.1206772
24 sg:pub.10.1111/j.1745-7254.2007.00554.x
25 schema:datePublished 2013-09-13
26 schema:datePublishedReg 2013-09-13
27 schema:description Insulin-like growth factor-I receptor (IGF-IR) signaling is required for carcinogenicity and tumor development, and this pathway has not been well studied in human esophageal carcinomas. Esophageal cancer is one of the human cancers with the worst prognosis and has two main histologies: squamous cell carcinomas (ESCC) and adenocarcinoma (EAC). Previously, we have reported that detection of the IGF axis may be useful for the prediction of recurrence and poor prognosis of ESCC. We have also shown the successful therapy for several gastrointestinal cancers using recombinant adenoviruses expressing dominant negative IGF-IR (ad-IGF-IR/dn). The aim of this study is to develop potential targeted therapeutics to IGF-IR and to assess the effect of IGF-IR blockade in both of these types of esophageal cancer. We determined immunohistochemical expression of IGF-IR in a tissue microarray. We then assessed the effect of IGF-IR blockade on signal transduction, proliferation, apoptosis, and motility. Ad-IGF-IR/dn, a tyrosine kinase inhibitor, BMS-536924, and adenovirus expressing shRNA for IGF-IR were used. IGF-IR expression was common in both tumor types but not in normal tissues. IGF-IR was detected in metastatic sites at similar levels compared to the primary site. IGF-IR inhibition suppressed proliferation and colony formation in both cancers. IGF-IR blockades up-regulated both stress- and chemotherapy-induced apoptosis and reduced migration. Although IGF-IR/dn blocked ligand-induced activation of Akt-1 mainly, BMS-536924 effectively blocked both activation of Akt and MAPK. The IGF axis might play a key role in tumor progression of esophageal carcinomas. The IGF-IR targeting strategies might thus be useful anticancer therapeutics for human esophageal malignancies.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf N42c4f511e0e24988bee685a5ceee6fcf
31 N71fa314934774ee28242f6e8c00b447c
32 sg:journal.1091981
33 schema:keywords Ad-IGF
34 Akt
35 Akt-1
36 BMS-536924
37 DN
38 ESCC
39 IGF axis
40 IGF-IR
41 IGF-IR blockade
42 IGF-IR expression
43 IGF-IR inhibition
44 IGF-IR/
45 MAPK
46 activation
47 activation of Akt
48 adenocarcinoma
49 adenovirus
50 aim
51 anticancer therapeutics
52 apoptosis
53 axis
54 blockade
55 cancer
56 carcinogenicity
57 carcinoma
58 cell carcinoma
59 chemotherapy-induced apoptosis
60 colony formation
61 detection
62 development
63 dominant negative IGF-IR
64 effect
65 esophageal cancer
66 esophageal carcinoma
67 esophageal malignancy
68 esophageal squamous cell carcinoma
69 expression
70 formation
71 gastrointestinal cancer
72 histology
73 human cancers
74 human esophageal carcinoma
75 human esophageal squamous cell carcinoma
76 immunohistochemical expression
77 inhibition
78 inhibitors
79 insulin-like growth factor-I receptor (IGF-IR) signaling
80 key role
81 kinase inhibitors
82 levels
83 ligand-induced activation
84 main histology
85 malignancy
86 metastatic sites
87 microarray
88 migration
89 motility
90 normal tissues
91 pathway
92 poor prognosis
93 prediction
94 prediction of recurrence
95 primary site
96 prognosis
97 progression
98 proliferation
99 receptor blockade
100 receptor signaling
101 recombinant adenovirus
102 recurrence
103 role
104 shRNA
105 signal transduction
106 signaling
107 similar levels
108 sites
109 squamous cell carcinoma
110 strategies
111 stress
112 study
113 successful therapy
114 therapeutics
115 therapy
116 tissue
117 tissue microarray
118 transduction
119 tumor development
120 tumor progression
121 tumor types
122 types
123 tyrosine kinase inhibitors
124 worse prognosis
125 schema:name The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma
126 schema:pagination 973-985
127 schema:productId N28ec25fd78d1496d87deb67e7a208703
128 N6da6e4fb6e314897afe4fc027dde8344
129 Ncea94261387c465f97e4115b8605c0ef
130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000207016
131 https://doi.org/10.1007/s13277-013-1131-2
132 schema:sdDatePublished 2022-08-04T17:02
133 schema:sdLicense https://scigraph.springernature.com/explorer/license/
134 schema:sdPublisher Na85d39b27cc14a388001a73c26567e98
135 schema:url https://doi.org/10.1007/s13277-013-1131-2
136 sgo:license sg:explorer/license/
137 sgo:sdDataset articles
138 rdf:type schema:ScholarlyArticle
139 N0479583821db4ec5a7176d670fbaaf65 rdf:first sg:person.0762051764.57
140 rdf:rest Nc1c7724b95294e3ba518e9f74ce2d054
141 N0e626a586c824d839c0c9b2b2a503b66 rdf:first sg:person.01371070550.51
142 rdf:rest Nc304f00e09b34a5a8dd2a54b9db5e156
143 N0e6a26be96254e6a929773df3af746a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Prognosis
145 rdf:type schema:DefinedTerm
146 N28ec25fd78d1496d87deb67e7a208703 schema:name doi
147 schema:value 10.1007/s13277-013-1131-2
148 rdf:type schema:PropertyValue
149 N290c8a21be8747d6bf00015d4b581a67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Receptor, IGF Type 1
151 rdf:type schema:DefinedTerm
152 N2bdf4f9843044158bfcbcb91bd8ef4cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Carcinoma, Squamous Cell
154 rdf:type schema:DefinedTerm
155 N305ff2f6227c4c6e90a1ab4b8680a467 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Insulin-Like Growth Factor I
157 rdf:type schema:DefinedTerm
158 N345582aea88d4de59deabf4f4a2c23e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Signal Transduction
160 rdf:type schema:DefinedTerm
161 N40ab97e75a0f4ebda6898b302cb4a60f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Esophageal Squamous Cell Carcinoma
163 rdf:type schema:DefinedTerm
164 N42c4f511e0e24988bee685a5ceee6fcf schema:issueNumber 2
165 rdf:type schema:PublicationIssue
166 N5058c8aa27e3432db8e86d88f07b5907 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Adenocarcinoma
168 rdf:type schema:DefinedTerm
169 N55d2a1b81a134e2caf48a8d38bdddadd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Gene Expression Regulation, Neoplastic
171 rdf:type schema:DefinedTerm
172 N5aba8c82b0814094bf7579b4c456fe8a rdf:first sg:person.01074665575.51
173 rdf:rest Nd7299db15ce34402985dfc31aa408baa
174 N6da6e4fb6e314897afe4fc027dde8344 schema:name pubmed_id
175 schema:value 24026884
176 rdf:type schema:PropertyValue
177 N6e046224dbd046119eda76c788b76da4 rdf:first sg:person.0635431612.98
178 rdf:rest Nf15f52b6286d4acdb7c7074148417219
179 N71fa314934774ee28242f6e8c00b447c schema:volumeNumber 35
180 rdf:type schema:PublicationVolume
181 N8b8355ab1126484aaf96738b740f2580 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Humans
183 rdf:type schema:DefinedTerm
184 N9e90d51ecd284d2c8399b2c00bf0800c rdf:first sg:person.01301010573.05
185 rdf:rest N0479583821db4ec5a7176d670fbaaf65
186 Na33a60dc950a441f85b057f0823e8832 rdf:first sg:person.013060476532.17
187 rdf:rest Nbbd2f589630c4e6ab65b453fc3b20ce4
188 Na85d39b27cc14a388001a73c26567e98 schema:name Springer Nature - SN SciGraph project
189 rdf:type schema:Organization
190 Nac34de5afef44d6db20252574df37701 rdf:first sg:person.01274720725.67
191 rdf:rest N5aba8c82b0814094bf7579b4c456fe8a
192 Nbbd2f589630c4e6ab65b453fc3b20ce4 rdf:first sg:person.01317767674.34
193 rdf:rest N9e90d51ecd284d2c8399b2c00bf0800c
194 Nc1c7724b95294e3ba518e9f74ce2d054 rdf:first sg:person.0643127340.79
195 rdf:rest rdf:nil
196 Nc304f00e09b34a5a8dd2a54b9db5e156 rdf:first sg:person.01072025765.03
197 rdf:rest N6e046224dbd046119eda76c788b76da4
198 Nc9c84975349a4671a1778ced9d687cc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Adenoviridae
200 rdf:type schema:DefinedTerm
201 Ncdf6d9e64c8d4e2ca61b9615916129ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Esophageal Neoplasms
203 rdf:type schema:DefinedTerm
204 Ncea94261387c465f97e4115b8605c0ef schema:name dimensions_id
205 schema:value pub.1000207016
206 rdf:type schema:PropertyValue
207 Nd7299db15ce34402985dfc31aa408baa rdf:first sg:person.014315602124.12
208 rdf:rest Na33a60dc950a441f85b057f0823e8832
209 Nd9565dc8453f4d5ab18475068522e3dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Cell Line, Tumor
211 rdf:type schema:DefinedTerm
212 Nef78446823b24a2398534db8c0e0a975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Molecular Targeted Therapy
214 rdf:type schema:DefinedTerm
215 Nef831876dc314821810957bd5b41bbb6 rdf:first sg:person.01110335104.97
216 rdf:rest N0e626a586c824d839c0c9b2b2a503b66
217 Nf15f52b6286d4acdb7c7074148417219 rdf:first sg:person.0764564242.02
218 rdf:rest Nac34de5afef44d6db20252574df37701
219 Nfa2c1c325a3f439589a20edc59aea1d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Carcinogenesis
221 rdf:type schema:DefinedTerm
222 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
223 schema:name Medical and Health Sciences
224 rdf:type schema:DefinedTerm
225 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
226 schema:name Oncology and Carcinogenesis
227 rdf:type schema:DefinedTerm
228 sg:grant.6029765 http://pending.schema.org/fundedItem sg:pub.10.1007/s13277-013-1131-2
229 rdf:type schema:MonetaryGrant
230 sg:grant.6047187 http://pending.schema.org/fundedItem sg:pub.10.1007/s13277-013-1131-2
231 rdf:type schema:MonetaryGrant
232 sg:grant.6060341 http://pending.schema.org/fundedItem sg:pub.10.1007/s13277-013-1131-2
233 rdf:type schema:MonetaryGrant
234 sg:grant.6069476 http://pending.schema.org/fundedItem sg:pub.10.1007/s13277-013-1131-2
235 rdf:type schema:MonetaryGrant
236 sg:grant.6092555 http://pending.schema.org/fundedItem sg:pub.10.1007/s13277-013-1131-2
237 rdf:type schema:MonetaryGrant
238 sg:grant.6155796 http://pending.schema.org/fundedItem sg:pub.10.1007/s13277-013-1131-2
239 rdf:type schema:MonetaryGrant
240 sg:journal.1091981 schema:issn 1010-4283
241 1423-0380
242 schema:name Tumor Biology
243 schema:publisher Springer Nature
244 rdf:type schema:Periodical
245 sg:person.01072025765.03 schema:affiliation grid-institutes:grid.263171.0
246 schema:familyName Imsumran
247 schema:givenName Arisa
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072025765.03
249 rdf:type schema:Person
250 sg:person.01074665575.51 schema:affiliation grid-institutes:grid.263171.0
251 schema:familyName Nosho
252 schema:givenName Katsuhiko
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074665575.51
254 rdf:type schema:Person
255 sg:person.01110335104.97 schema:affiliation grid-institutes:grid.263171.0
256 schema:familyName Adachi
257 schema:givenName Yasushi
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110335104.97
259 rdf:type schema:Person
260 sg:person.01274720725.67 schema:affiliation grid-institutes:grid.26999.3d
261 schema:familyName Taniguchi
262 schema:givenName Hiroaki
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274720725.67
264 rdf:type schema:Person
265 sg:person.01301010573.05 schema:affiliation grid-institutes:grid.261331.4
266 schema:familyName Carbone
267 schema:givenName David P
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301010573.05
269 rdf:type schema:Person
270 sg:person.013060476532.17 schema:affiliation grid-institutes:grid.263171.0
271 schema:familyName Sasaki
272 schema:givenName Yasushi
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013060476532.17
274 rdf:type schema:Person
275 sg:person.01317767674.34 schema:affiliation grid-institutes:grid.263171.0
276 schema:familyName Arimura
277 schema:givenName Yoshiaki
278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317767674.34
279 rdf:type schema:Person
280 sg:person.01371070550.51 schema:affiliation grid-institutes:grid.263171.0
281 schema:familyName Ohashi
282 schema:givenName Hirokazu
283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371070550.51
284 rdf:type schema:Person
285 sg:person.014315602124.12 schema:affiliation grid-institutes:grid.263171.0
286 schema:familyName Suzuki
287 schema:givenName Hiromu
288 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014315602124.12
289 rdf:type schema:Person
290 sg:person.0635431612.98 schema:affiliation grid-institutes:grid.263171.0
291 schema:familyName Yamamoto
292 schema:givenName Hiroyuki
293 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635431612.98
294 rdf:type schema:Person
295 sg:person.0643127340.79 schema:affiliation grid-institutes:grid.263171.0
296 schema:familyName Shinomura
297 schema:givenName Yasuhisa
298 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643127340.79
299 rdf:type schema:Person
300 sg:person.0762051764.57 schema:affiliation grid-institutes:grid.26999.3d
301 schema:familyName Imai
302 schema:givenName Kohzoh
303 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762051764.57
304 rdf:type schema:Person
305 sg:person.0764564242.02 schema:affiliation grid-institutes:grid.263171.0
306 schema:familyName Matsunaga
307 schema:givenName Yasutaka
308 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764564242.02
309 rdf:type schema:Person
310 sg:pub.10.1007/bf02254995 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011834346
311 https://doi.org/10.1007/bf02254995
312 rdf:type schema:CreativeWork
313 sg:pub.10.1007/s00535-009-0151-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023037865
314 https://doi.org/10.1007/s00535-009-0151-6
315 rdf:type schema:CreativeWork
316 sg:pub.10.1007/s10495-010-0555-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1042036765
317 https://doi.org/10.1007/s10495-010-0555-z
318 rdf:type schema:CreativeWork
319 sg:pub.10.1038/ajg.2011.417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014758355
320 https://doi.org/10.1038/ajg.2011.417
321 rdf:type schema:CreativeWork
322 sg:pub.10.1038/sj.cgt.7700524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018453497
323 https://doi.org/10.1038/sj.cgt.7700524
324 rdf:type schema:CreativeWork
325 sg:pub.10.1038/sj.onc.1206772 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038051388
326 https://doi.org/10.1038/sj.onc.1206772
327 rdf:type schema:CreativeWork
328 sg:pub.10.1111/j.1745-7254.2007.00554.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1042563001
329 https://doi.org/10.1111/j.1745-7254.2007.00554.x
330 rdf:type schema:CreativeWork
331 grid-institutes:grid.261331.4 schema:alternateName James Thoracic Center, The Ohio State University, Columbus, OH, USA
332 schema:name James Thoracic Center, The Ohio State University, Columbus, OH, USA
333 rdf:type schema:Organization
334 grid-institutes:grid.263171.0 schema:alternateName First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan
335 schema:name First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan
336 rdf:type schema:Organization
337 grid-institutes:grid.26999.3d schema:alternateName The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
338 schema:name First Department of Internal Medicine, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan
339 The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
340 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...